[Swiss clinical practice guidelines for skin cancer in organ transplant recipients]

Publikation

[Swiss clinical practice guidelines for skin cancer in organ transplant recipients]

Wissenschaftlicher Artikel/Review - 28.04.2010

Lapointe A-K, Serra A, Pelloni F, Pascual M, Kempf W, Hunger R, Binet Françoise-Isabelle, Arnold A, Anliker Mark, Hofbauer G, Laffitte E

Bereiche

Dermatologie | Venerologie | Allergologie, Nephrologie | Transplantationsmedizin

PubMed

20455382

Zitation

Lapointe A, Serra A, Pelloni F, Pascual M, Kempf W, Hunger R, Binet F, Arnold A, Anliker M, Hofbauer G, Laffitte E. [Swiss clinical practice guidelines for skin cancer in organ transplant recipients]. Rev Med Suisse 2010; 6:854-9.

Art

Wissenschaftlicher Artikel/Review (Deutsch)

Zeitschrift

Rev Med Suisse 2010; 6

Veröffentlichungsdatum

28.04.2010

ISSN (Druck)

1660-9379

Seiten

854-9

Kurzbeschreibung/Zielsetzung

Swiss clinical practice guidelines for skin cancer in organ transplant recipients Transplant patients have increased over the last decades. As a consequence of long-term immunosuppression, skin cancer, in particular squamous cell carcinoma (SCC), has become an important problem. Screening and education of potential organ transplant recipients (OTRs) regarding prevention of sun damage and early recognition of skin cancer are important before transplantation. Once transplanted, OTRs should be seen yearly by a dermatologist to ensure compliance with sun avoidance as well as for treatment of precancerosis and SCC. Early removal is the best treatment for SCC. Reduction of immunosuppression, switch to mTOR inhibitors and chemoprevention with acitretin may reduce the incidence of SCC. The dermatological follow-up of OTRs should be integrated into a comprehensive post-transplant management strategy.